The Expanding Role of Biomarkers in the Assessment of Smoking-Related Parenchymal Lung Diseases

Chest - United States
doi 10.1378/chest.12-1540
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Expanding the Spectrum of Particle-And Fiber-Associated Interstitial Lung Diseases

Turk Toraks Dergisi
PulmonaryRespiratory Medicine
2014English

Transbronchial Cryobiopsy Validity in Diagnosing Diffuse Parenchymal Lung Diseases in Egyptian Population

Journal of Multidisciplinary Healthcare
MedicineNursing
2019English

The Role of Mast Cells in IgE-Independent Lung Diseases

Clinical Reviews in Allergy and Immunology
MedicineAllergyImmunology
2020English

Asbestos-Related Diseases and Blood Biomarkers

2020English

Role of Advanced Neuroimaging, Fluid Biomarkers and Genetic Testing in the Assessment of Sport-Related Concussion: A Systematic Review

British Journal of Sports Medicine
Sports MedicinePhysical TherapySports ScienceSports TherapyOrthopedicsMedicineRehabilitation
2017English

Smoking-Related Diffuse Cystic Lung Disease

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2018English

P016 Vascular Involvement in Rheumatic Diseases – The Role of Imaging and Immunological Biomarkers

2019English

Pulmonary Hypertension in Diffuse Parenchymal Lung Diseases — Is There Any Benefit of PAH-specific Therapy?

Advances in Respiratory Medicine
PulmonaryRespiratory Medicine
2017English

Diagnostic Yield and Safety of Cryoprobe Transbronchial Lung Biopsy in Diffuse Parenchymal Lung Diseases: Systematic Review and Meta-Analysis

Respiratory Care
MedicinePulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy